The Role of AI in Clinical Trials

Authors: Alberich-Bayarri, Ángel, Mayorga-Ruiz, Irene, López-González, Rafael, Fos-Guarinos, Belén, García-Castro, Fabio, Jiménez-Pastor, Ana

Source: Artificial Intelligence in Medical Imaging : Opportunities, Applications and Risks. 2019, p231-243.

Combination of radiomic and biomarker signatures as exploratory objective in a phase II trial with intratumoral BO-112 plus pembrolizumab for advanced melanoma.

Authors: Marquez-Rodas, Ivan, Dalle, Stéphane, Castanon, Eduardo, Sanmamed, Miguel F., Arance, Ana Maria, Cerezuela-Fuentes, Pablo, Martin Huertas, Roberto, Rodríguez-Moreno, Juan Francisco, Gonzalez-Cao, Maria, Muñoz-Couselo, Eva, Martin-Liberal, Juan, Rodriguez-Abreu, Delvys, Alberich-Bayarri, Ángel, Mayorga-Ruiz, Irene, Molina Vila, Miguel Angel, Román, Ruth, Chaney, Marya F., Sánchez López, Javier, Maciá, Sonia, Quintero, Marisol

Source: Journal of clinical oncology. 39(15 suppl):TPS9586-TPS9586

Availability: http://explore.bl.uk/primo_library/libweb/action/display.do?tabs=detailsTab&gathStatTab=true&ct=display&fn=search&doc=ETOCvdc_100173224120.0x000001&indx=1&recIds=ETOCvdc_100173224120.0x000001

Prognostic Value of Radiomics Signature By Diagnostic 18F-FDG PET/CT Analysis in Aggressive Non-Hodgkin's Lymphoma

Authors: Ferrer Lores, Blanca ^*, Mayorga-Ruiz, Irene ^*, Alberich Bayarri, Angel ^*, Morello-González, Daniella ^*, Pastor-Galán, Irene ^*, Navarro-Cubells, Blanca ^*, Serrano, Alicia ^*, Teruel, Ana Isabel ^*, Dosdá-Muñoz, Rosa ^*, Solano, Carlos, Marti-Bonmati, Luis ^*, Terol, Maria Jose ^*

Source: In Blood 29 November 2018 132 Supplement 1:1703-1703